Qingkun Song

1.6k total citations
76 papers, 1.2k citations indexed

About

Qingkun Song is a scholar working on Oncology, Surgery and Immunology. According to data from OpenAlex, Qingkun Song has authored 76 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 20 papers in Surgery and 16 papers in Immunology. Recurrent topics in Qingkun Song's work include Cancer Immunotherapy and Biomarkers (20 papers), Esophageal Cancer Research and Treatment (14 papers) and Immunotherapy and Immune Responses (11 papers). Qingkun Song is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), Esophageal Cancer Research and Treatment (14 papers) and Immunotherapy and Immune Responses (11 papers). Qingkun Song collaborates with scholars based in China, United States and Australia. Qingkun Song's co-authors include Yuchen Li, Jun Ren, David C. Christiani, Jiangping Wu, Bryan W. Day, Xiudong Guan, Yanjie Zhao, Wang Jia, Quan Zhou and George Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Qingkun Song

70 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingkun Song China 19 486 270 209 184 178 76 1.2k
Shaoli Zhang China 17 276 0.6× 328 1.2× 193 0.9× 171 0.9× 142 0.8× 44 1.1k
Iris Burkholder Germany 19 363 0.7× 343 1.3× 66 0.3× 356 1.9× 191 1.1× 62 1.4k
Diana Lenzner United States 18 539 1.1× 249 0.9× 301 1.4× 225 1.2× 97 0.5× 23 1.1k
Nikolaus Becker Germany 20 444 0.9× 255 0.9× 156 0.7× 69 0.4× 165 0.9× 40 1.3k
Ying Tsai United States 19 473 1.0× 330 1.2× 292 1.4× 250 1.4× 242 1.4× 37 1.2k
Niels Kokot United States 19 350 0.7× 393 1.5× 264 1.3× 186 1.0× 149 0.8× 78 1.3k
Ivan Paunović Serbia 21 285 0.6× 286 1.1× 246 1.2× 89 0.5× 132 0.7× 139 1.6k
Tsai‐Yun Chen Taiwan 19 257 0.5× 247 0.9× 146 0.7× 79 0.4× 77 0.4× 97 1.1k
H. A. Risch United States 11 516 1.1× 303 1.1× 101 0.5× 107 0.6× 234 1.3× 12 1.6k

Countries citing papers authored by Qingkun Song

Since Specialization
Citations

This map shows the geographic impact of Qingkun Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingkun Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingkun Song more than expected).

Fields of papers citing papers by Qingkun Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingkun Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingkun Song. The network helps show where Qingkun Song may publish in the future.

Co-authorship network of co-authors of Qingkun Song

This figure shows the co-authorship network connecting the top 25 collaborators of Qingkun Song. A scholar is included among the top collaborators of Qingkun Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingkun Song. Qingkun Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Weiping, Jianping Wu, Hong Xiao, et al.. (2025). Clofazimine enhances anti-PD-1 immunotherapy in glioblastoma by inhibiting Wnt6 signaling and modulating the tumor immune microenvironment. Cancer Immunology Immunotherapy. 74(4). 137–137. 2 indexed citations
3.
Wu, Jiangping, Xin Ou, Feng Shi, et al.. (2025). Peripheral TNF-α and CD8+/CD28+ T Lymphocytes as Alternatives for PD-L1 Prediction in Breast Cancer Tumor Microenvironment: Stratified by Neoadjuvant Therapy. Breast Cancer Targets and Therapy. Volume 17. 627–637.
6.
Song, Qingkun, Fang Li, Yu Cao, et al.. (2023). Real-World Effectiveness of Nirmatrelvir/Ritonavir and Dexamethasone Among Hospitalized Patients with COVID-19: A Prospective Cohort Study. Infection and Drug Resistance. Volume 16. 5223–5231.
7.
Zhao, Yanjie, et al.. (2022). Diagnostic Efficacy of CT Examination on Early Detection of Lung Cancer during Pandemic of COVID-19. Diagnostics. 12(10). 2317–2317. 2 indexed citations
8.
Li, Yuchen, Yanjie Zhao, Feng Shi, et al.. (2022). Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer. Breast Cancer Targets and Therapy. Volume 14. 391–403. 8 indexed citations
9.
Liu, Kuiliang, Yanjie Zhao, Feng Shi, et al.. (2022). High Serum Squamous Cell Carcinoma Antigen Level Associated with Remission of Mild/Moderate Dysplasia of the Esophagus: A Nested Case–Control Study. Gastroenterology Research and Practice. 2022. 1–6. 2 indexed citations
10.
Xie, Ting, Dayong Wu, Suqing Li, et al.. (2020). microRNA-582 Potentiates Liver and Lung Metastasis of Gastric Carcinoma Cells Through the FOXO3-Mediated PI3K/Akt/Snail Pathway. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Feng, Jian, et al.. (2020). Minimal-access retroperitoneal pancreatic necrosectomy for infected necrotizing pancreatitis: a multicentre study of a step-up approach. British journal of surgery. 107(10). 1344–1353. 8 indexed citations
12.
Li, Yuchen, et al.. (2019). Increased risk of esophageal squamous cell carcinoma associated with frequent and long-term consumption of salted meat and salted fat. Journal of International Medical Research. 47(8). 3841–3849. 9 indexed citations
14.
Zhao, Yanjie, Jian Zhang, Feng Shi, et al.. (2018). Expression of PD-1 on CD4+Tumor-Infiltrating Lymphocytes in Tumor Microenvironment Associated with Pathological Characteristics of Breast Cancer. Journal of Immunology Research. 2018. 1–8. 13 indexed citations
15.
16.
Sheng, Minjia, Feng Shi, Yanjie Zhao, et al.. (2018). Dysfunctional phagocytosis capacity, granulocyte recruitment and inflammatory factor secretion of Kupffer cells in diabetes mellitus reversed by Lidocaine. Diabetes Metabolic Syndrome and Obesity. Volume 11. 827–834. 4 indexed citations
17.
Li, Shifei, et al.. (2017). Sclerostin induced tumor growth, bone metastasis and osteolysis in breast cancer. Scientific Reports. 7(1). 11399–11399. 41 indexed citations
18.
Liu, Xudong, Xiaorong Wang, Sihao Lin, et al.. (2015). Reproducibility and Validity of a Food Frequency Questionnaire for Assessing Dietary Consumption via the Dietary Pattern Method in a Chinese Rural Population. PLoS ONE. 10(7). e0134627–e0134627. 41 indexed citations
19.
Song, Qingkun, Rong Huang, Jing Li, et al.. (2013). The Diverse Distribution of Risk Factors between Breast Cancer Subtypes of ER, PR and HER2: A 10-Year Retrospective Multi-Center Study in China. PLoS ONE. 8(8). e72175–e72175. 20 indexed citations
20.
Zheng, Shan, Jing Li, Jin‐Hu Fan, et al.. (2012). The pathologic characteristics of breast cancer in China and its shift during 1999–2008: A national‐wide multicenter cross‐sectional image over 10 years. International Journal of Cancer. 131(11). 2622–2631. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026